کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
3988780 | 1258593 | 2016 | 5 صفحه PDF | دانلود رایگان |
عنوان انگلیسی مقاله ISI
Salvage therapy of imatinib-resistant hypereosinophilic syndrome with PDGFRB rearrangement
دانلود مقاله + سفارش ترجمه
دانلود مقاله ISI انگلیسی
رایگان برای ایرانیان
کلمات کلیدی
موضوعات مرتبط
علوم پزشکی و سلامت
پزشکی و دندانپزشکی
تومور شناسی
پیش نمایش صفحه اول مقاله
![عکس صفحه اول مقاله: Salvage therapy of imatinib-resistant hypereosinophilic syndrome with PDGFRB rearrangement Salvage therapy of imatinib-resistant hypereosinophilic syndrome with PDGFRB rearrangement](/preview/png/3988780.png)
چکیده انگلیسی
Hypereosinophilic syndrome (HES) has generally been defined as a peripheral blood eosinophil count greater than 1500/mm3 and may be associated with tissue damage. Imatinib is customarily used as the first-line therapy for HES with gene abnormalities, such as PDGFRA or PDGFRB. We presented a case where the patient was diagnosed with HES, with PDGFRB rearrangement. The patient began an imatinib regimen after diagnosis and then developed resistance to imatinib. The combination of dasatinib, methylprednisolone and hydroxyurea was administered to the patient as the salvage therapy.
ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Journal of Cancer Research and Practice - Volume 3, Issue 1, March 2016, Pages 23–27
Journal: Journal of Cancer Research and Practice - Volume 3, Issue 1, March 2016, Pages 23–27
نویسندگان
Miao-Erh Chang, Hao-Wei Teng,